YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ)

0.01 +0.00% (+0.00)

Over 5Y: -96.9%

2026-08-27
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

0.5 1
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 98.3K Q3 '21 — Operating Cash Flow: -30.8K Q3 '21 — Net Income: -336.6K Q4 '21 — Revenue: 332.3K Q4 '21 — Operating Cash Flow: -63.7K Q4 '21 — Net Income: -397.2K Q1 '22 — Revenue: 15.2K Q1 '22 — Operating Cash Flow: 51K Q1 '22 — Net Income: -578.9K Q2 '22 — Revenue: 8K Q2 '22 — Operating Cash Flow: -17.6K Q2 '22 — Net Income: -491.6K Q3 '22 — Revenue: 14.6K Q3 '22 — Operating Cash Flow: 55.2K Q3 '22 — Net Income: -238.1K Q4 '22 — Revenue: 66.5K Q4 '22 — Operating Cash Flow: -689.5K Q4 '22 — Net Income: 103.6K Q1 '23 — Revenue: 156.6K Q1 '23 — Operating Cash Flow: -32.7K Q1 '23 — Net Income: -316.7K Q2 '23 — Revenue: 1.4K Q2 '23 — Operating Cash Flow: -153K Q2 '23 — Net Income: -367.3K Q3 '23 — Revenue: 428.5K Q3 '23 — Operating Cash Flow: 5.1K Q3 '23 — Net Income: 6.3K Q4 '23 — Revenue: 22.3K Q4 '23 — Operating Cash Flow: -558.4K Q4 '23 — Net Income: -517.4K Q1 '24 — Revenue: 3.5K Q1 '24 — Operating Cash Flow: -330.6K Q1 '24 — Net Income: -377.3K Q2 '24 — Revenue: 0 Q2 '24 — Operating Cash Flow: -427.7K Q2 '24 — Net Income: -527.5K Q3 '24 — Revenue: 0 Q3 '24 — Operating Cash Flow: 353.3K Q3 '24 — Net Income: -621.1K Q4 '24 — Revenue: -18 Q4 '24 — Operating Cash Flow: -932.7K Q4 '24 — Net Income: -146.7K Q1 '25 — Revenue: 0 Q1 '25 — Operating Cash Flow: -392K Q1 '25 — Net Income: -435.6K Q2 '25 — Revenue: 0 Q2 '25 — Operating Cash Flow: -14K Q2 '25 — Net Income: -230.3K Q3 '25 — Revenue: 0 Q3 '25 — Operating Cash Flow: -308K Q3 '25 — Net Income: -310.2K Q4 '25 — Revenue: 12.4K Q4 '25 — Operating Cash Flow: -128.8K Q4 '25 — Net Income: -177K Q1 '26 — Revenue: 0 Q1 '26 — Operating Cash Flow: -207.2K Q1 '26 — Net Income: -272.6K Q2 '26 — Revenue: 0 Q2 '26 — Operating Cash Flow: -84.1K Q2 '26 — Net Income: -247.9K -900K -600K -300K 0 300K 600K
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

10.0
Accruals -41.6%
Gross margin 66.1%
Asset turnover 0.018×
ROA -149.9%
Capex / sales —
EBITDA margin —
FCF margin —
OCF / EBIT —
OCF margin —
OE margin —
Oper. margin —
Profit margin —
ROCE —
ROE —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.7
ND/EBITDA —
Cash runway 0.016 yr
Current ratio 0.18×
Debt payback 0.0 yr
F-score 3.4 pts
Quick ratio 0.17×
Cash / Debt —
Debt / Eq —
Equity / Assets —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.6
Sales CAGR 4Y -68.4%
Sales/sh Y/Y -58979.1%
Shares change +16.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.